These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 19527708)
1. Pharmacological characterization of the inhibition by moxonidine and agmatine on the cardioaccelerator sympathetic outflow in pithed rats. Cobos-Puc LE; Villalón CM; Ramírez-Rosas MB; Sánchez-López A; Lozano-Cuenca J; Gómez-Díaz B; MaassenVanDenBrink A; Centurión D Eur J Pharmacol; 2009 Aug; 616(1-3):175-82. PubMed ID: 19527708 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological analysis of the cardiac sympatho-inhibitory actions of moxonidine and agmatine in pithed spontaneously hypertensive rats. Cobos-Puc LE; Sánchez-López A; Centurión D Eur J Pharmacol; 2016 Nov; 791():25-36. PubMed ID: 27565220 [TBL] [Abstract][Full Text] [Related]
3. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats. Monroy-Ordoñez EB; Villalón CM; Cobos-Puc LE; Márquez-Conde JA; Sánchez-López A; Centurión D Auton Neurosci; 2008 Dec; 143(1-2):40-5. PubMed ID: 18774761 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats. Rubio-Beltrán E; Labastida-Ramírez A; Hernández-Abreu O; MaassenVanDenBrink A; Villalón CM Eur J Pharmacol; 2017 Oct; 812():97-103. PubMed ID: 28694067 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats. Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological evidence that alpha2A- and alpha2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats. Cobos-Puc LE; Villalón CM; Sánchez-López A; Lozano-Cuenca J; Pertz HH; Görnemann T; Centurión D Eur J Pharmacol; 2007 Jan; 554(2-3):205-11. PubMed ID: 17109851 [TBL] [Abstract][Full Text] [Related]
7. The α2-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with α2A, α2B and α2C subtypes. Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D Eur J Pharmacol; 2013 Oct; 718(1-3):245-52. PubMed ID: 24028939 [TBL] [Abstract][Full Text] [Related]
8. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors. Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597 [TBL] [Abstract][Full Text] [Related]
9. Further analysis of the inhibition by agmatine on the cardiac sympathetic outflow: Role of the α Cobos-Puc L; Aguayo-Morales H; Ventura-Sobrevilla J; Luque-Contreras D; Chin-Chan M Eur J Pharmacol; 2017 Jun; 805():75-83. PubMed ID: 28315344 [TBL] [Abstract][Full Text] [Related]
10. Further evidence for the role of histamine H3, but not H1, H2 or H4, receptors in immepip-induced inhibition of the rat cardioaccelerator sympathetic outflow. Pinacho-García M; Marichal-Cancino BA; Villalón CM Eur J Pharmacol; 2016 Feb; 773():85-92. PubMed ID: 26826593 [TBL] [Abstract][Full Text] [Related]
11. Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptors. Schäfer U; Burgdorf C; Engelhardt A; Kurz T; Richardt G J Pharmacol Exp Ther; 2002 Dec; 303(3):1163-70. PubMed ID: 12438540 [TBL] [Abstract][Full Text] [Related]
13. Differential cardiac sympatho-inhibitory responses produced by the agonists B-HT 933, quinpirole and immepip in normoglycaemic and diabetic pithed rats. Rivera-Mancilla E; Altamirano-Espinoza AH; Manrique-Maldonado G; Villanueva-Castillo B; Villalón CM Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):767-778. PubMed ID: 29675928 [TBL] [Abstract][Full Text] [Related]
14. Chronic 5-HT García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological evidence that dopamine inhibits the cardioaccelerator sympathetic outflow via D2-like receptors in pithed rats. Alcántara-Vázquez O; Villamil-Hernández MT; Sánchez-López A; Centurión D J Pharmacol Sci; 2013; 123(4):380-91. PubMed ID: 24225403 [TBL] [Abstract][Full Text] [Related]
16. α2A-adrenoceptors, but not nitric oxide, mediate the peripheral cardiac sympatho-inhibition of moxonidine. Cobos-Puc LE; Aguayo-Morales H; Silva-Belmares Y; González-Zavala MA; Centurión D Eur J Pharmacol; 2016 Jul; 782():35-43. PubMed ID: 27112661 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of ergotamine-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats. Cobos-Puc LE; Villalón CM; Sánchez-López A; Ramírez-Rosas MB; Lozano-Cuenca J; Pertz HH; Görnemann T; Centurión D Naunyn Schmiedebergs Arch Pharmacol; 2009 Feb; 379(2):137-48. PubMed ID: 18779954 [TBL] [Abstract][Full Text] [Related]
18. Modification of noradrenaline release in pithed spontaneously hypertensive rats by I1-binding sites in addition to alpha2-adrenoceptors. Raasch W; Jungbluth B; Schäfer U; Häuser W; Dominiak P J Pharmacol Exp Ther; 2003 Mar; 304(3):1063-71. PubMed ID: 12604683 [TBL] [Abstract][Full Text] [Related]
19. The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats. Altamirano-Espinoza AH; González-Hernández A; Manrique-Maldonado G; Marichal-Cancino BA; Ruiz-Salinas I; Villalón CM Br J Pharmacol; 2013 Nov; 170(5):1102-11. PubMed ID: 24032529 [TBL] [Abstract][Full Text] [Related]
20. Norepinephrine release is reduced by I(1)-receptors in addition to alpha(2)-adrenoceptors. Raasch W; Jungbluth B; Schäfer U; Häuser W; Dominiak P Ann N Y Acad Sci; 2003 Dec; 1009():270-3. PubMed ID: 15028598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]